Literature DB >> 16806475

Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss.

Alberto Bosque1, Isabel Marzo, Javier Naval, Alberto Anel.   

Abstract

The mechanisms responsible for the down-modulation of the activation of separated CD4(+) or CD8(+) human T cell blasts were studied using cells obtained from healthy donors. In the absence of IL-2, human CD4(+) T cell blasts were sensitive to both FasL and Apo2L/TRAIL, but human CD8(+) T cell blasts died, with no additional effect of death receptor ligation. CD8(+) T cell blasts were more sensitive than CD4(+) T cell blasts to apoptosis induction by IL-2 deprivation, which was associated with a decrease in the expression of anti-apoptotic proteins of the Bcl-2 family, especially of Mcl-1 in CD8(+) T cell blasts. The maintenance of high levels of Bim expression was also necessary, since down-modulation of Bim expression by siRNA in normal human CD8(+) T cell blasts greatly reduced apoptosis by IL-2 deprivation. These data, together with previous works, point to an important role of the presence or absence of immuno-stimulatory cytokines in the type of regulation of human CD8(+) T cell responses (death by cytokine deprivation versus death receptor inhibition of cytokine-dependent growth).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806475     DOI: 10.1016/j.molimm.2006.04.029

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

2.  Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis.

Authors:  Daniel J Neitzke; Jacob S Bowers; Kristina Andrijauskaite; Nathaniel S O'Connell; Elizabeth Garrett-Mayer; John Wrangle; Zihai Li; Chrystal M Paulos; David J Cole; Mark P Rubinstein
Journal:  Cancer Immunol Immunother       Date:  2017-03-09       Impact factor: 6.968

3.  Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta.

Authors:  Wing-Yiu Lee; Peter Hampson; Lydia Coulthard; Farrah Ali; Mike Salmon; Janet M Lord; Dagmar Scheel-Toellner
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

4.  Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival.

Authors:  Wen Qing Li; Tad Guszczynski; Julie A Hixon; Scott K Durum
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

5.  A disintegrin and metalloproteinase domain-15 deficiency leads to exaggerated cigarette smoke-induced chronic obstructive pulmonary disease (COPD)-like disease in mice.

Authors:  Xiaoyun Wang; Joselyn Rojas-Quintero; Duo Zhang; Takahiro Nakajima; Katherine H Walker; Hong Yong Peh; Yuhong Li; Quynh-Anh Fucci; Yohannes Tesfaigzi; Caroline A Owen
Journal:  Mucosal Immunol       Date:  2020-07-20       Impact factor: 7.313

6.  Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.

Authors:  Keli L Hippen; Paul Harker-Murray; Stephen B Porter; Sarah C Merkel; Aryel Londer; Dawn K Taylor; Megan Bina; Angela Panoskaltsis-Mortari; Pablo Rubinstein; Nico Van Rooijen; Tatiana N Golovina; Megan M Suhoski; Jeffrey S Miller; John E Wagner; Carl H June; James L Riley; Bruce R Blazar
Journal:  Blood       Date:  2008-07-21       Impact factor: 22.113

7.  AKT family and miRNAs expression in IL-2 induced CD4(+)T cells.

Authors:  Najmeh Ranji; Majid Sadeghizadeh; Morteza Karimipoor; Mohammad Ali Shokrgozar; Reza Ebrahimzadeh-Vesal
Journal:  Iran J Basic Med Sci       Date:  2014-11       Impact factor: 2.699

8.  Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.

Authors:  Parthav Jailwala; Jill Waukau; Sanja Glisic; Srikanta Jana; Sarah Ehlenbach; Martin Hessner; Ramin Alemzadeh; Shigemi Matsuyama; Purushottam Laud; Xujing Wang; Soumitra Ghosh
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

Review 9.  Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.

Authors:  Sandeep Nayar; Prokar Dasgupta; Christine Galustian
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.